Coliprotec Indications
Coliprotec is an oral live vaccine recommended for vaccination of weaner piglets as an aid to preventing post-weaning diarrhea caused by F4(K88)-positive E. coli.
It is recommended to vaccinate healthy weaned pigs of 17 or more days. Diarrhea associated with F4-positive E. coli is generally observed in the first two weeks after weaning. Economic losses can be significant, particularly due to weight loss, weight heterogeneity, cost of treatment, concomitant diseases, management of sick animals and mortality, which can affect up to 20% of animals. Clinical symptoms vary widely from farm to farm and F4-positive E. coli can also cause significant health and performance problems during the lactation of piglets (maternity), and later in nursery and early finishing.
Coliprotec is now a first-rate alternative to antibiotics, the efficacy of the later being limited by antimicrobial resistance (i.e. increasing resistance of bacteria to antibiotics). In addition, the use of antibiotics is subject to growing health and social concerns.
Supplied in multidose vials, the vaccine can be administered orally in drinking water. This eliminates the laborious logistics of animal handling and injections.
For more information, see the Package Insert and Technical Bulletin.
It is recommended to vaccinate healthy weaned pigs of 17 or more days. Diarrhea associated with F4-positive E. coli is generally observed in the first two weeks after weaning. Economic losses can be significant, particularly due to weight loss, weight heterogeneity, cost of treatment, concomitant diseases, management of sick animals and mortality, which can affect up to 20% of animals. Clinical symptoms vary widely from farm to farm and F4-positive E. coli can also cause significant health and performance problems during the lactation of piglets (maternity), and later in nursery and early finishing.
Coliprotec is now a first-rate alternative to antibiotics, the efficacy of the later being limited by antimicrobial resistance (i.e. increasing resistance of bacteria to antibiotics). In addition, the use of antibiotics is subject to growing health and social concerns.
Supplied in multidose vials, the vaccine can be administered orally in drinking water. This eliminates the laborious logistics of animal handling and injections.
For more information, see the Package Insert and Technical Bulletin.